Medicare Enrolled
Dr. Cherese Laporta, D.O.
Family Medicine · Patchogue, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Laporta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Laporta?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Laporta
Dr. Cherese Laporta is a family medicine specialist in Patchogue, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Laporta performed 5,058 Medicare services across 2,860 unique beneficiaries.
Between the years covered by Open Payments, Dr. Laporta received a total of $12,503 from 56 pharmaceutical and/or device companies across 670 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Laporta is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 3% volume in NY
$12,503 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,058
Medicare services
Top 3% in NY for family medicine
2,860
Unique beneficiaries
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~266 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,976 | $75 | $350 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
585 | $2 | $20 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
399 | $151 | $506 |
| Annual depression screening | 350 | $22 | $80 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
334 | $116 | $400 |
| COVID-19 immunoassay detection test A laboratory test that uses an immunoassay method to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) through direct visual observation. |
169 | $41 | $100 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
162 | $12 | $90 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
124 | $12 | $114 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
97 | $57 | $72 |
| Stool test for blood to screen for colon tumors A test that analyzes a stool sample to detect hidden blood, which is used to screen for colon tumors. |
86 | $4 | $72 |
| Influenza virus detection test A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation. |
83 | $16 | $160 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
67 | $1 | $10 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
63 | $110 | $444 |
| Health risk assessment administration and interpretation This procedure involves administering a health risk assessment to a patient and interpreting the results. |
62 | $3 | $10 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
58 | $42 | $53 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
56 | $21 | $150 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
48 | $51 | $250 |
| Complex chronic care management, first 60 minutes This service involves clinical staff time directed by a healthcare professional to manage two or more chronic conditions over a calendar month. It covers the first 60 minutes of this coordinated care effort. |
40 | $124 | $156 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
37 | $260 | $668 |
| Additional chronic care management time, 60 minutes This service covers an additional 60 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions, billed per calendar month. |
36 | $66 | $83 |
| Strep A rapid test A rapid test to detect Group A Streptococcus bacteria using an immunoassay method with direct visual observation. |
26 | $16 | $30 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
25 | $161 | $500 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
25 | $107 | $462 |
| Removal of noncancer skin growth, 0.6-1.0 cm This procedure involves the removal of a benign skin growth located on the body, arms, or legs. The growth removed measures between 0.6 and 1.0 centimeters in diameter. |
22 | $122 | $692 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
21 | $154 | $450 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
20 | $161 | $870 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
19 | $81 | $400 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
18 | $192 | $400 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
14 | $46 | $238 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
14 | $77 | $150 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
11 | $194 | $706 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
11 | $0 | $20 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$12,503
Total received (2018-2024)
Avg $1,786/year across 7 years
Top 4% in NY for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
670
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,367 (98.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$136 (1.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,288
2023
$1,520
2022
$1,236
2021
$1,886
2020
$1,829
2019
$2,314
2018
$2,430
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$160
Lilly USA, LLC
$145
Amgen Inc.
$137
AstraZeneca Pharmaceuticals LP
$105
ABBVIE INC.
$94
GlaxoSmithKline, LLC.
$93
Indivior Inc.
$72
Exact Sciences Corporation
$66
Braeburn Inc.
$62
Intra-Sana Laboratories
$59
Boehringer Ingelheim Pharmaceuticals, Inc.
$59
Sumitomo Pharma America, Inc.
$58
Astellas Pharma US Inc
$44
Orexo US, Inc.
$36
Seqirus USA Inc
$22
Inspire Medical Systems, Inc.
$20
Abbott Laboratories
$19
IDORSIA PHARMACEUTICALS US INC
$18
GENZYME CORPORATION
$18
Top 3 companies account for 34.4% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,347
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,062
AstraZeneca Pharmaceuticals LP
$959
Lilly USA, LLC
$925
Amgen Inc.
$916
GlaxoSmithKline, LLC.
$897
Merck Sharp & Dohme Corporation
$800
PFIZER INC.
$640
Takeda Pharmaceuticals U.S.A., Inc.
$575
ABBVIE INC.
$413
Alkermes, Inc.
$382
Allergan, Inc.
$380
Janssen Pharmaceuticals, Inc
$255
Indivior Inc.
$226
AbbVie Inc.
$218
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$199
Amarin Pharma Inc.
$190
SANOFI-AVENTIS U.S. LLC
$188
Bausch Health US, LLC
$150
Orexo US, Inc.
$131
Allergan Inc.
$130
Novartis Pharmaceuticals Corporation
$116
Merz North America, Inc.
$109
Abbott Laboratories
$102
Exact Sciences Corporation
$94
Braeburn Inc.
$86
Regeneron Healthcare Solutions, Inc.
$80
IDORSIA PHARMACEUTICALS US INC
$78
US WorldMeds, LLC
$76
Grifols USA, LLC
$72
Astellas Pharma US Inc
$61
Intra-Sana Laboratories
$59
Sumitomo Pharma America, Inc.
$58
Kowa Pharmaceuticals America, Inc.
$52
Eisai Inc.
$49
West-Ward Pharmaceuticals
$41
Althera Pharmaceuticals LLC
$39
SCILEX PHARMACEUTICALS INC.
$35
Hikma Pharmaceuticals USA
$25
Seqirus USA Inc
$22
BioXcel Therapeutics, Inc.
$21
Inspire Medical Systems, Inc.
$20
Shire North American Group Inc
$20
Genentech USA, Inc.
$20
Gilead Sciences, Inc.
$19
Horizon Therapeutics plc
$18
GENZYME CORPORATION
$18
INSYS Therapeutics Inc
$17
Axsome Therapeutics, Inc.
$17
Biohaven Pharmaceutical Holding Company Ltd.
$16
Paratek Pharmaceuticals, Inc.
$16
SANOFI PASTEUR INC.
$13
Otsuka America Pharmaceutical, Inc.
$13
Horizon Pharma plc
$13
AcelRx Pharmaceuticals, Inc.
$12
Eyevance Pharmaceuticals LLC
$11
Top 3 companies account for 26.9% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · ANORO · ANORO ELLIPTA · APLENZIN · AREXVY · Aimovig · BASAGLAR · BOTOX · BREO · BREZTRI · BRIXADI · BYDUREON · BYSTOLIC · CHANTIX · Cologuard Collection Kit · DSUVIA · DUEXIS · DUPIXENT · Dayvigo · Descovy · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FABRAZYME · FARXIGA · FASENRA · FLUZONE HIGH-DOSE · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Flucelvax · FreeStyle Libre · FreeStyle Libre 2 · GARDASIL 9 · GEMTESA · IGALMI · INSPIRE · JANUVIA · JARDIANCE · LINZESS · LOKELMA · Livalo · Lucemyra/Lofexidine · MIGRANAL · MOUNJARO · Mitigare · NURTEC ODT · NUZYRA · OFEV · Otezla · Ozempic · PAXLOVID · PENNSAID · PNEUMOVAX 23 · PRALUENT · PREMARIN · PREVNAR - 13 · PREVNAR 13 · Prolastin-C Liquid · Prolia · QULIPTA · QUVIVIQ · RELTONE 200 MG · REXULTI · RYBELSUS · Repatha · Roszet · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STEGLATRO · SUBLOCADE · SYMBICORT · SYNDROS · SYNJARDY · SYNTHROID · Sunosi · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TRUMENBA · Tobradex ST · Tresiba · Trintellix · UBRELVY · VESICARE · VIBERZI · VIVITROL · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · Vivitrol · Vivitrol 380 mg · Wegovy · XARELTO · XEOMIN · XIFAXAN · Xofluza · ZEPBOUND · ZERBAXA · ZTLido · Zubsolv
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for family medicine in NY.
Geographic Context
Family medicine physicians within 10 mi
470
Per 100K population
30.8
County median income
$128,329
Nearest hospital
LONG ISLAND COMMUNITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Laporta is a clinical cardiology specialist, with above-average Medicare volume (top 3% in NY), with low-engagement industry engagement in the top 4% of NY peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Laporta experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Laporta performed 1,976 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Laporta receive payments from pharmaceutical companies?
Yes. Dr. Laporta received a total of $12,503 from 56 companies across 670 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Laporta's costs compare to other family medicine physicians in Patchogue?
Dr. Laporta's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Laporta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Patchogue
Browse family medicine physicians in Patchogue ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in NY
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in NY
Which NY family medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology